Clinical Trial Detail

NCT ID NCT01685125
Title Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

prostate cancer

Therapies

Dasatinib

Abiraterone

Age Groups: adult

No variant requirements are available.